Skip to main content
logo
eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 17, 2026, 4:00 PM EST

eFFECTOR Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
--3.551.4342-
Revenue Growth
--148.46%-96.59%--
Gross Profit
-21.62-22.92-19.76-18.5320.17-23.89
Operating Income
-32.7-33.84-32.4-31.915.82-28.61
Net Income
-34.63-35.81-22.6715.80.17-14.21
Earnings Per Share
-12.42-16.37-13.7611.002.82-297.06
EPS Growth
---290.68%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
25.3818.3726.3149.715.223.43
Total Debt
20.2520.5520.2820.0312.9615.25
Net Cash (Debt)
5.14-2.186.0329.672.26-11.82
Net Cash Growth
---79.68%1215.83%--
Net Cash Per Share
1.84-0.993.6620.6021.23-247.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-29.19-29.55-25.9-24.8913.84-27.6
Capital Expenditures
-0.08-0.1-0.19-0.04-0.15-0
Free Cash Flow
-29.28-29.65-26.09-24.9313.68-27.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
----48.02%-
Operating Margin
---911.99%-2230.56%37.66%-
Pretax Margin
---637.91%1104.76%34.67%-
Profit Margin
---637.91%1104.75%0.40%-
FCF Margin
---734.34%-1743.36%32.57%-

Valuation
Chart
Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingAug '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PE Ratio
---21.16--
PS Ratio
--5.04233.76--